Drugs / Doxorubicin-Eluting Beads
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01004978 Background | Oct 2009 → Feb 2021 | hepatocellular carcinoma | National Cancer Institute (NCI) | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Doxorubicin-Eluting Beads | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01004978 ↗ |